Ir para o conteúdo principal

United States Últimas notícias

Todas as matérias desta categoria, das mais recentes às mais antigas.

Bloomberg

Oil Pares Gains Above $100 Amid Report of Reserves Release

Oil prices rose to above $100 a barrel as the conflict in the Middle East continues. Brent spiked as much as 29% to $119.50 a barrel. Prices pared gains after the Financial Times reported that Group of Seven finance ministers will discuss a possible joint release of oil from reserves co-ordinated with the International Energy Agency on Monday. Bloomberg's Stephen Stapczynski breaks down the situation.

Leia mais: Oil Pares Gains Above $100 Amid Report of Reserves Release
Bloomberg

US Equities Are Getting Dragged Into Global Selloff

Selling swept across regions and asset classes as the war in the Middle East added fresh stress to markets that are already under pressure from AI disruptions and worries about the potential for cracks in credit markets. The escalating crisis has left investors caught between the risk of renewed inflation stemming from elevated oil prices and signs of cooling in the US labor market. Bloomberg's Mark Cranfield has the latest.

Leia mais: US Equities Are Getting Dragged Into Global Selloff

Grafa
Technology

Anthropic sues U.S. Government over ‘supply chain risk’ designation

Anthropic PBC filed two federal lawsuits Monday challenging the Pentagon’s decision to label the artificial intelligence startup a “supply chain risk,” an unprecedented move following the company’s refusal to permit unrestricted military use of its Claude chatbot.

Leia mais: Anthropic sues U.S. Government over ‘supply chain risk’ designation
Grafa
Health

Precision BioSciences gains FDA fast track status for Duchenne gene editor

Precision BioSciences (NASDAQ:DTIL) shares are in focus after the U.S. Food and Drug Administration granted Fast Track designation to PBGENE-DMD, an investigational in vivo gene editing therapy designed to treat Duchenne muscular dystrophy (DMD).

Leia mais: Precision BioSciences gains FDA fast track status for Duchenne gene editor